U.S. market Closed. Opens in 10 hours 47 minutes

HROWM | Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue130.19M88.59M72.48M48.87M51.16M41.37M
Cost of Revenue39.64M25.38M18.21M14.46M16.75M16.52M
Gross Profit90.55M63.21M54.26M34.41M34.42M24.85M
Operating Expenses90.12M61.39M52.50M34.32M34.69M30.07M
Selling, General & Admin83.09M58.24M41.31M31.25M32.61M29.24M
Research & Development6.65M3.15M11.19M3.07M2.08M825.00K
Other Operating Expenses380.00KN/AN/AN/A0N/A
Operating Income431.00K1.82M1.76M89.00K-275.00K-5.22M
Other Expenses / Income-24.14M-15.93M-19.74M-4.16M158.00K19.84M
Before Tax Income-23.71M-14.11M-17.98M-4.07M-117.00K14.62M
Income Tax Expenses701.00K-26.00K32.00K-655.00K8.00KN/A
Net Income-24.41M-14.09M-18.01M-3.36M168.00K14.62M
Interest Expenses21.32M7.24M5.44M2.24M2.50M2.73M
Basic Shares Outstanding32.62M27.46M26.76M25.90M25.32M23.81M
Diluted Shares Outstanding32.62M27.46M26.76M25.90M26.47M23.81M
EBITDA11.95M5.48M4.16M2.83M2.39M-3.37M
EBITDA Margin9.18%6.19%5.74%5.79%4.67%-8.16%
EBIT-2.39M-6.87M-12.54M-1.78M2.68M17.35M
EBIT Margin-1.83%-7.75%-17.30%-3.63%5.23%41.94%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙